Ambareesh Baliga, Managing Partner-Global Wealth Management of Edelweiss Financial Services told CNBC-TV18, "We see the auto ancillary space doing extremely well going ahead especially the export oriented, Bharat Forge is one stock which we are recommending. We have been recommending Motherson Sumi Systems for the last couple of weeks and in pharmaceutical space it is Dishman Pharmaceuticals & Chemicals where after this scare, which we got in the last quarter when the results were not up to the mark, they have bounced back with extremely good results this time."
"Dishman Pharma is back on our list. In fact we see a level of about Rs 110-120 for that stock," he adds.
On November 05, 2013 Dishman Pharmaceuticals & Chemicals closed at Rs 76.55, up Re 1, or 1.32 percent.
The share touched its 52-week high Rs 124.50 and 52-week low Rs 37.05 on 05 December, 2012 and 02 August, 2013, respectively.
Anda sedang membaca artikel tentang
Dishman Pharma may test Rs 110-120: Ambareesh Baliga
Dengan url
http://untukkesehatanda.blogspot.com/2013/11/dishman-pharma-may-test-rs-110-120.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Dishman Pharma may test Rs 110-120: Ambareesh Baliga
namun jangan lupa untuk meletakkan link
Dishman Pharma may test Rs 110-120: Ambareesh Baliga
sebagai sumbernya
0 komentar:
Posting Komentar